Skip to main content

Table 1 Statistical analysis of PCSD1 tumor volumes at each time point

From: PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche

IF Tumor Volume at Week:

5

6

6.5

7

7.5

Vehicle

760.511232

1360.8478

2735.197608

2855.33404

3390.372544

Bicalutamide

699.844704

1614.89276

2663.83624

2463.068608

2358.286112

p value

0.841

0.151

1

0.222

0.151

SC Tumor Volume at Week:

5

5.5

6

6.5

7

Vehicle

791.58599

1529.06611

1390.5021

1693.31617

2833.35351

Bicalutamide

717.73988

1005.140552

568.0168

1243.851128

1460.162808

p value

0.905

0.19

0.19

0.413

0.286